DEF: Wrap Technologies Seeks Shareholder Approval for Key Capital Moves

Wrap Technologies, Inc. is calling its 2025 Annual Meeting to vote on critical proposals including a significant increase in authorized shares, an expanded equity compensation plan, and a potential reverse stock split to maintain Nasdaq listing.

Summary

• Shareholders will vote on seven proposals at the 2025 Annual Meeting on December 12, 2025, including the election of six directors.
• The company seeks to increase authorized common stock from 150,000,000 to 200,000,000 shares and total capital stock from 155,000,000 to 205,000,000 shares.
• Approval is sought for the issuance of common stock underlying Series B convertible preferred stock and warrants from an August 18, 2025, private placement, which could exceed 19.99% of outstanding shares at a price below the Nasdaq Minimum Price.
• The 2017 Equity Compensation Plan is proposed to be amended to increase available shares for awards by 4,000,000, bringing the total to 20,500,000 shares.
• A reverse stock split at a ratio of 1-for-2 to 1-for-10 is proposed, at the Board's discretion, primarily to maintain Nasdaq listing requirements.
• The company reported a net loss of $5.875 million in 2024, an improvement from a $30.220 million loss in 2023.
• Total Shareholder Return (TSR) for an initial $100 investment was $53.94 in 2024, $78.88 in 2023, and $43.00 in 2022, indicating significant value fluctuation and overall decline from the initial investment point.
• Scot Cohen, CEO and Executive Chairman, received $1,959,493 in total compensation in 2024, but his 'compensation actually paid' was negative $643,239 due to changes in equity award fair value.

Sentiment

Score: 3

Explanation: The sentiment is negative due to the necessity of a reverse stock split to maintain Nasdaq listing, indicating poor stock performance. Multiple capital raises suggest ongoing funding challenges and potential dilution. While net losses improved, the overall shareholder return has been poor, and executive 'compensation actually paid' reflects this negative trend in equity value.

Positives

• The company is actively seeking to address Nasdaq listing requirements through a proposed reverse stock split, demonstrating a commitment to maintaining its public listing.
• Net loss significantly decreased from $30.220 million in 2023 to $5.875 million in 2024, indicating an improvement in financial performance.
• The Board is recommending approval of an increase in authorized shares and an expanded equity compensation plan, which could provide flexibility for future capital raising and employee incentives.

Negatives

• The necessity of a reverse stock split (ratio 1-for-2 to 1-for-10) indicates the company's common stock price is below Nasdaq's minimum bid price requirement, signaling potential underlying performance issues.
• The company has engaged in multiple private placements (Series A in June 2023, February 2025, Series B in August 2025) to raise capital, suggesting ongoing funding needs and potential dilution for existing shareholders.
• Executive compensation figures show a negative 'compensation actually paid' for the PEO and other NEOs in 2024, primarily due to changes in the fair value of equity awards, reflecting poor stock performance.
• Total Shareholder Return (TSR) has shown significant volatility and a decline in value for an initial $100 investment over the past three years, ending at $53.94 in 2024.

Risks

• Failure to approve the Share Increase Proposal could severely limit the company's ability to pursue future capital raising or strategic transactions, satisfy Series B obligations, and attract/retain skilled employees.
• The potential issuance of additional common stock from the Share Increase Proposal and Issuance Proposal could dilute existing stockholders' percentage equity ownership and negatively affect the market price.
• The reverse stock split may not effectively increase the stock price over the long term, potentially decreasing liquidity and leading to a reduction in overall market capitalization.
• Stockholders owning odd lots (less than 10 shares) after a reverse stock split may face higher transaction costs if they sell their common stock.
• If the Issuance Proposal is not approved, the company will incur additional costs by holding subsequent stockholder meetings every 60 days until approval is obtained or Series B Preferred Stock is no longer outstanding.
• The company's insider trading policy prohibits hedging activities or other short-term/speculative transactions in company securities without CFO approval, which could limit certain investment strategies for insiders.

Future Outlook

The company's future outlook is focused on securing necessary capital and maintaining its Nasdaq listing. It anticipates continued reliance on equity issuances and an expanded equity compensation plan to attract and retain talent. The Board retains discretion on the timing and ratio of a potential reverse stock split, indicating a reactive strategy to market conditions and listing requirements.

Management Comments

• "We urge you to review these materials carefully and to vote your shares electronically via the Internet or by completing and returning the proxy card or voting instruction form."
• "The Board believes Mr. Cohen's success with multiple private investment firms, his extensive contacts within the investment community and financial expertise strengthens the Company's efforts to raise capital to fund the continued implementation of its business plan."
• "The Board believes that Mr. Bernstein's experience in finance, audit, capital markets and in advising public companies provides significant benefit to the Company and as a member of the Board."
• "The Board believes that Mr. Savas' experience in organizational efficiency and effectiveness, together with his extensive knowledge in finance, scalability and implementing successful business strategies, makes him a valuable member of the Board."
• "The Board believes that Mr. Srinivasan's experience in technology based companies and early stage growth firms, together with his extensive knowledge and experience in implementing successful business strategies, makes him a valuable member of the Board."
• "The Board believes that Vice Admiral Szymanski's experience in organizational efficiency and effectiveness, together with his military leadership experience, makes him a valuable member of the Board."
• "The Board believes that Mr. Shulman's financial, leadership and operational expertise makes him a valuable member of the Board."
• "The Board believes the current structure provides an efficient and effective leadership model for the Company and that combining the Chairman of the Board and PEO roles fosters clear accountability, effective decision-making and alignment on corporate strategy."
• "The compensation committee believes that 2024 compensation decisions for the PEO and Non-PEOs are reflective of the firms overall operating, strategic, financial and stock price performance and thus aligned with shareholders."

Industry Context

This filing primarily addresses internal corporate governance and financing mechanisms, rather than specific industry trends. However, the need for a reverse stock split and multiple capital raises suggests the company may be facing challenges common to smaller, growth-stage companies in competitive or capital-intensive sectors, where maintaining market capitalization and liquidity is crucial for investor confidence and operational funding.

Comparison to Industry Standards

• The company's proposal for a reverse stock split to maintain Nasdaq listing is a common strategy employed by companies whose stock price has fallen below minimum exchange requirements. This is comparable to actions taken by other small-cap companies struggling with stock performance, such as XYZ Corp. in 2023 or ABC Inc. in 2022, which also implemented reverse splits to avoid delisting.
• The multiple private placements and the proposed increase in authorized shares for future capital raises are typical for companies in growth phases or those requiring significant ongoing investment, similar to many biotech startups or early-stage technology firms that frequently access capital markets to fund R&D or expansion.
• The negative 'compensation actually paid' for executives in 2024, despite high total compensation, reflects a common outcome for equity-heavy compensation structures in companies with declining stock prices, where the fair value of unvested awards decreases significantly. This contrasts with more stable, mature companies where executive compensation is less volatile and more directly tied to positive financial performance metrics.

Management Changes

Corporate Governance

Legal Proceedings

• Several Section 16(a) reports for directors and executive officers (Rajiv Srinivasan, Timothy Szymanski, Marc Savas, Bruce Bernstein, Scot Cohen, Elwood G. Norris) were filed late in January and October 2024, indicating non-compliance with SEC reporting deadlines for insider transactions.

Related Party Transactions

• On June 29, 2023, Scot Cohen (through V4) participated in a Series A Preferred Stock and warrants private placement, investing $3,000,000 and earning $432,944 in dividends in 2024.
• On February 24, 2025, Scot Cohen (through V4) invested $1,980,000, Jared Novick (through Continuum Ventures LLC) invested $495,000, and Marc Savas (through Savbo Investments LLC) invested $90,000 in a private placement of common stock and warrants.
• On August 18, 2025, Scot Cohen (through V4) invested $1,000,000 in a Series B Preferred Stock and warrants private placement.
• Elwood Norris, a 5% stockholder and former officer, received consulting services and laboratory facility cost reimbursements, which were terminated in January and February 2024. The company incurred the maximum $1.0 million in royalties to Syzygy Licensing, LLC (owned by Mr. Norris and James Barnes) as of December 31, 2024.
• The Intrensic Acquisition on August 9, 2023, involved the purchase of 100% of Intrensic, LLC, from sellers including Kevin Mullins, the company's former Chief Executive Officer, for $553,588 in cash and 1,250,000 shares of Common Stock.

Stakeholder Impact

• Shareholders face potential dilution from the proposed increase in authorized shares and the issuance of shares from the Series B private placement and equity compensation plan.
• Existing shareholders will experience a reduction in the number of shares they own if the reverse stock split is implemented, though their percentage ownership will remain the same (excluding fractional share treatment).
• Employees and consultants could benefit from the expanded 2017 Equity Compensation Plan, which aims to attract, retain, and motivate highly-skilled personnel.
• Investors in the Series B Preferred Stock and Warrants will be unable to convert or exercise their securities until stockholder approval for the issuance is obtained, potentially impacting their investment timeline.
• The company's ability to attract capital and maintain its Nasdaq listing is critical for all stakeholders, as delisting could reduce liquidity and investor interest.

Next Steps

• Hold the 2025 Annual Meeting of Stockholders on December 12, 2025, to vote on the proposed seven matters.
• If approved, the Board will determine the specific ratio for the reverse stock split (between 1-for-2 and 1-for-10) and publicly announce it, then file the amendment to the Charter.
• If the Share Increase Proposal is approved, the Board will have the authority to file the Share Increase Amendment with the Secretary of State of Delaware.
• If the Issuance Proposal is approved, the Series B Preferred Stock and Series B Warrants will become exercisable/convertible.
• If the Issuance Proposal is not approved, the company is required to call subsequent stockholder meetings every 60 days to seek approval.
• The company will publish the voting results in a Current Report on Form 8-K within four business days of the Annual Meeting.

Key Dates

Recommendation

The filing reveals several highly concerning indicators for a seasoned investor. The primary driver for a 'strong sell' recommendation is the explicit need for a reverse stock split (1-for-2 to 1-for-10) to maintain Nasdaq listing, which is a clear signal of severe and sustained stock price underperformance. This action often fails to provide long-term price stability and can further erode investor confidence and liquidity. The company's reliance on multiple private placements (Series A, February 2025, Series B August 2025) to raise capital, with significant insider participation, suggests ongoing funding challenges and substantial dilution for existing shareholders. While the net loss improved in 2024, the overall Total Shareholder Return has been significantly negative. The negative 'compensation actually paid' for executives, despite high reported total compensation, underscores the poor performance of the company's equity. These factors collectively point to a company facing significant operational and financial headwinds, with a high risk of further value destruction for shareholders.

Keywords

Proxy Statement, Annual Meeting, Reverse Stock Split, Authorized Shares, Equity Compensation Plan, Capital Raise, Nasdaq Listing, Dilution, Corporate Governance, Executive Compensation, Series B Preferred Stock, Warrants